Abstract: A method is provided for preventing or treating toxemia during pregnancy by administering a thromboxane A.sub.2 receptor antagonist before or during toxemia.

Abstract: A pharmaceutical composition is provided which is in the form of a plurality of beadlets, adapted to be filled into pharmaceutical hard shell capsules, or compressed into tablets, which beadlets are formed of a pharmaceutical such as an ACE inhibitor, for example, captopril, a beta-blocker such as nadolol, propranolol or atenolol, a calcium channel blocker such as diltiazem or nifedipine or other pharmaceuticals including combinations thereof, binder such as microcrystalline cellulose, and at least 5% by weight of an acid processing aid, such as citric acid, which imparts plasticity to the wet mass needed for efficient extrusion and spheronization. A method for forming beadlets is also provided which includes the steps of extruding a composition as described above, and subjecting the resulting extrudate to a spheronization step wherein an acid processing aid such as citric acid is employed to improve processing and form improved beadlets.

Abstract: A dispenser is provided which is especially useful in dispensing measured doses of topical preparations such as creams or ointments. The dispenser includes a container for holding a supply of topical preparation. A plunger assembly is operatively mounted to the container and includes a plunger piston and a plunger shaft which carries a series of longitudinally disposed teeth. The piston and plunger shaft include communicating openings. A cap seals off the mouth of the container. A portion of the plunger shaft extends through the cap externally of the container. A lever assembly is pivotally mounted on the cap and is operatively associated with the plunger shaft and piston, the lever assembly including teeth engaging means adapted to interact with the teeth of the plunger shaft.

Abstract: A process is provided for preparing the keto-phosphonate ##STR1## in enantiomerically homogeneous form, by reacting the anhydride ##STR2## with S-.alpha.-methylbenzylamine to effect diastereoselective opening of the anhydride to give a mixture of amides ##STR3## separating the amides, for example, by frictional crystallization, and converting the desired amide IVA (which is obtained in high yield from the anhydride) to enantiomerically homogeneous ketophosphonate in high yield and on a large scale.The so-formed ketophosphonate is useful in the synthesis of compactin as well as 7-substituted-(3,5-dihydroxy)-hept-6-enoic and -heptanoic acid HMG-CoA reductase inhibitors.

Abstract: The present catheter employee a series of axial slits adjacent to its tip. The slits act to increase the flexibility of the catheter adjacent the tip thereby providing pressure relief in the event of blockage of the lumen at the tip. In addition, by forming the slits as slots, i.e. by removing material from the slits, it is possible to provide a catheter having flow through the sides adjacent to the tip for any desired purpose.

Abstract: A dispensing device for a radionuclide generator includes an eluant container, a receptacle for receiving the container, the receptacle being in sliding engagement with a support, a hollow needle which pierces the elastic stopper of the container so that the tip of the needle penetrates into the container, and a fixing device for holding the needle at a distance from its tip. The volume dispensed from the container is controlled by shifting the receptacle up or down within the support along the longitudinal axis of the needle.

Abstract: Antibacterial activity is exhibited by .beta.

Abstract: Acylmercaptoalkanoyl compounds of the formula ##STR1## wherein n is an integer from one to fifteen possess enkephalinase inhibition activity and are useful as analgesic agents.

Abstract: A device for wound management permits the application of an apertured pad to the wound and involves the provision of a protective compartment, optionally drained, whose interior is open to the wound and which is normally sealed closed but which can be opened if desired.

Abstract: An improved multi-lumen catheter having lumens which do not extend in a straight line down the length of the catheter is disclosed. The twisting of the catheter provides that side holes which extend into the lumens of the catheter are not aligned in a straight line. Accordingly, when the catheter is inserted into a patient's vessel, the side holes cannot be aligned in a manner which causes all of the side holes of a particular lumen to be occluded by the wall of the patient's vessel.A catheter of the type disclosed can be manufactured by an extrusion process in which the catheter is twisted during the extrusion, or by heating a non-twisted catheter and then twisting it in order to impart an appropriate twist therein.

Abstract: In accordance with the present invention an improved adhesive structure for adhesion of an article to a fluid-emitting wound and the surrounding normal skin is disclosed. The adhesive structure comprises a first contact region comprised of a fluid-interactive adhesive material which provides adhesion to the wound and surrounding normal skin; a second contact region comprised of the same or a different adhesive material, which provides adhesion betweeen the first region, or another region integral with the first region, and the article; and, an absorbent region comprised of an absorbent fibrous, fabric or foam material intermediate the first and second regions whereby enhanced cohesion between the first and second regions and between the second region and the article, under conditions of heavy fluid emission, is provided.

Abstract: A controlled release pharmaceutical formulation is provided which releases a pharmaceutical of a basic character at a controlled rate regardless of the pH of the environment, which formulation includes a basic pharmaceutical, up to about 45% by weight of a pH dependent polymer which is a salt of alginic acid, such as sodium alginate, up to about 35% by weight of a pH-independent hydrocarbon gelling agent having a viscosity of up to about 100,000 centipoises in 2% solution at 20.degree. C., binder and excipients.

Abstract: Hypotensive activity is exhibited by compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof wherein R.sub.1 is hydrogen or alkyl;R.sub.2 and R.sub.3 are each independently phenyl, substituted phenyl, cycloalkyl, or R.sub.2 is hydrogen and R.sub.3 is heteroaryl;R.sub.4 and R.sub.5 are the same or different and each is hydrogen, hydroxy, alkoxy, alkanoyl or alkyl;R.sub.6 is hydrogen or alkyl; andn is 1, 2, 3 or 4; with the proviso that if R.sub.2 and R.sub.3 are each phenyl, at least one of R.sub.1, R.sub.4, R.sub.5 and R.sub.6 is other than hydrogen.

Abstract: Geminally-substituted cyclic ether carboxylic acids or derivatives thereof are provided which have the structure ##STR1## wherein Z is aryl, which may be optionally substituted with one or more of the following groups: halo, lower alkyl, lower alkoxy, hydroxy, lower alkylamino, phenyl or carbo-lower alkoxy ##STR2## R is COOH, COO alkali metal, coo lower alkyl, ##STR3## R.sup.1 is lower alkyl or aryl; n is 1 or 2;p is 2 to 5; andq is 1 to 4.These compounds are cardiovascular agents which exhibit thromboxane antagonist activity and thus are useful in the treatment of thrombotic disease.

Abstract: Arylhydroxamates are provided having the structure ##STR1## wherein R.sup.1 is hydrogen, lower alkyl, aryl, lower alkenyl, cycloalkyl, or aralkyl;R.sup.2 is hydrogen, lower alkyl, aryl, cycloalkyl, alkanoyl or aroyl;m is 2 to 8; andZ is ##STR2## wherein R.sup.3 is OH, COOH ##STR3## These compounds are useful as inhibitors of .DELTA..sup.5 -lipoxygenase and as such are useful as antiallergy agents.

Abstract: For any ostomy appliance, a body-side ostomy member includes a medical grade adhesive pad and a coupling having one part captive to but telescopically slidable relative to another part to provide access for the fingers or thumb of a wearer beneath a lateral flange of the coupling, when the parts are spaced from one another.This allows an ostomy coupling to be secured together without applying undue pressure to the sensitive body area of the wearer.

Abstract: Antibacterial activity is exhibited by 3-acylamino-2-oxoazetidines having in the 1-position an activating group of the formula ##STR1## wherein R is ##STR2## and R.sub.

Abstract: The device comprises a substantially cylindrical support member which carries or in part defines an inflatable cuff. The cuff extends for only a portion of the length of said support member. Means are provided for inflating the cuff with air and transmitting changes in pressure within the cuff to a display device such as a pressure gauge.

Abstract: The ostomy appliance has two interengaging coupling elements. One of the elements is an annular plate which includes an engaging member formed by two ribs which diverge from each other to define a V-formation. One of the ribs has a stepped formation on its distal region. The other coupling element has an annular channel having cooperating formation adapted to engage the stepped formation, thereby connecting the coupling elements.

Abstract: A composite skin barrier including a first adhesive component which fits around the stoma, a coupling element, and a second adhesive component which is flexible, light, and has a degree of porosity. The second adhesive component contacts the skin at a distance from the stoma.